Cargando…

Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?

Detalles Bibliográficos
Autores principales:	Latella, Giovanni, Viscido, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463724/ https://www.ncbi.nlm.nih.gov/pubmed/32717828 http://dx.doi.org/10.3390/cells9081762

Ejemplares similares

Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?
por: Pompili, Simona, et al.
Publicado: (2019)

Efficacy and adverse events of pirfenidone in treating idiopathic pulmonary fibrosis
por: Ren, Hui, et al.
Publicado: (2017)

Sunglasses to hide behind may also prevent melanoma of the eyes
por: Dhomen, Nathalie, et al.
Publicado: (2021)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido, Angelo, et al.
Publicado: (2019)

If these data could talk
por: Pasquier, Thomas, et al.
Publicado: (2017)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Role of pirfenidone in the management of pulmonary fibrosis
por: Meyer, Keith C, et al.
Publicado: (2017)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Persistent Iron Deficiency Anemia in Patients with Celiac Disease Despite a Gluten-Free Diet
por: Stefanelli, Gianpiero, et al.
Publicado: (2020)

Dietary Factors Modulating Colorectal Carcinogenesis
por: Vernia, Filippo, et al.
Publicado: (2021)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Could BCG be used to protect against COVID-19?
por: Redelman-Sidi, Gil
Publicado: (2020)

Better patient identification could help fight the coronavirus
por: Moscovitch, Ben, et al.
Publicado: (2020)

Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
por: Schattenberg, Jörn M., et al.
Publicado: (2022)

Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders
por: Valvano, Marco, et al.
Publicado: (2020)

Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications
por: Vernia, Filippo, et al.
Publicado: (2022)

IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in Europe
por: Duck, Annette, et al.
Publicado: (2015)

How COVID-19 could benefit tuberculosis and HIV services in South Africa
por: Keene, Claire, et al.
Publicado: (2020)

Could a good night's sleep improve COVID-19 vaccine efficacy?
por: Benedict, Christian, et al.
Publicado: (2021)

Gremlin 2 could explain the reduced capacity of browning of visceral adipose tissue
por: Moreno-Navarrete, José María
Publicado: (2022)

As Ye Sow That Shall Ye Also Reap
Publicado: (1899)

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
por: Yu, Wencheng, et al.
Publicado: (2016)

Could routine race-adjustment of spirometers exacerbate racial disparities in COVID-19 recovery?
por: Anderson, Meredith A, et al.
Publicado: (2021)

Planning to introduce novel tuberculosis vaccines in high burden settings: how could this be done?
por: Cotton, Mark F, et al.
Publicado: (2023)

Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants?
por: Jin, Pengfei, et al.
Publicado: (2023)

Pulmonary fibrosis secondary to COVID-19: a call to arms?
por: Spagnolo, Paolo, et al.
Publicado: (2020)

Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience
por: Alhamad, Esam H.
Publicado: (2015)

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
por: Salih, Goran Nadir, et al.
Publicado: (2016)

Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use
por: Lyseng-Williamson, Katherine A.
Publicado: (2017)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Pirfenidone-Induced Photosensitivity in a Patient with Idiopathic Pulmonary Fibrosis
por: Kim, Ho-Jin, et al.
Publicado: (2018)

Synthesis and evaluation of new pirfenidone derivatives as anti-fibrosis agents
por: Gu, Chenxi, et al.
Publicado: (2022)

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
por: Lancaster, Lisa H., et al.
Publicado: (2017)

Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin
por: Demirkol, Barış, et al.
Publicado: (2023)

Genetic variations in idiopathic pulmonary fibrosis and patient response to pirfenidone
por: Kubbara, Aahd, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_619l80goano7d7ar9rjuhbfbvn